2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk Donald M. Lloyd -Jones , Pamela B. Morris , Christie M. Ballantyne , Kim K. Birtcher , Ashleigh M. Covington , Sondra M. DePalma , Nicole M. Bhave , Margo B. Minissian , Carl E. Orringer , Sidney C. Smith , Ashley Arana Waring , John T. Wilkins , Niti R. Aggarwal , Biykem Bozkurt , John P. Erwin , Chayakrit Krittanawong , Dharam J. Kumbhani , Gurusher S. Panjrath , Javier A. Sala-Mercado , David E. Winchester , Megan Coylewright , T. A. Edward , Cathleen C. Gates , Richard J. Kovacs , Brendan Mullen , Joseph M. Allen , Amy Dearborn , Grace D. Ronan Journal of the American College of Cardiology（2022）
关键词
ACC Expert Consensus Decision Pathway, bempedoic acid cardiovascular disease, cholesterol, ezetimibe, inclisiran, LDL dyslipidemia, lipids, PCSK9 inhibitors, statins
AI 理解论文
溯源树
样例
